Value Bridge — INOVA FAIRFAX HOSPITAL
Current $193M → Target $246M (+$53.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$192.8M
Current EBITDA
$246.1M
Target EBITDA
+$53.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$12.1M
Payer Mix Optimization
$28.9M
Cost to Collect Reduction
$9.6M
Clean Claim Improvement
$7.2M
Volume & Rate Growth
$48.2M
What This Means
The 7-lever model projects a 28% EBITDA uplift from $193M to $246M. The highest-impact lever is Volume & Rate Growth at $19.3M probability-weighted.
IC talking point: "We see $53M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $586M in equity value creation."